DOI: https://doi.org/10.14710/jai.v0i0.62735

Predictors of Severity and Management of Severe Leptospirosis Patients in Intensive Care Unit

1Department of Anesthesiology and Intensive Therapy, Universitas Gadjah Mada Academic Hospital, Yogyakarta, Indonesia

2Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Nursing and Public Health, Gadjah Mada University, Yogyakarta, Indonesia

Received: 20 Mar 2024; Revised: 3 Sep 2024; Accepted: 13 Sep 2024; Published: .
Open Access Copyright 2021 JAI (Jurnal Anestesiologi Indonesia)
Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.

Citation Format:
Abstract

Background: Severe leptospirosis or Weil's syndrome occurs in 10% of leptospirosis cases, with a mortality rate of 5-40%. Misdiagnosis of leptospirosis often occurs due to nonspecific symptoms. Discussion of risk factors, causative agents, pathogenesis, clinical manifestations, diagnostic techniques, and predictors of disease severity are crucial for successful management.

Cases: We report 3 cases of leptospirosis with various clinical manifestations and management. In these 3 cases, older age was associated with severe leptospirosis and poor outcomes. The SPiRO score can identify patients with severe leptospirosis requiring ICU care. All three cases of leptospirosis were severe with complications in the kidneys, lungs, and hematological system requiring intensive care in the ICU.

Discussion: Early and appropriate management can reduce patient mortality rates. ICU management of leptospirosis includes antibiotics, fluid balance, and support for affected organs. Patients with respiratory failure are given oxygenation using high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), or invasive mechanical ventilation with endotracheal intubation (ETT). Acute kidney failure in leptospirosis can be managed with hemodialysis as indicated or may improve with conservative therapy. Corticosteroids may be administered for thrombocytopenia associated with leptospirosis.

Conclusion: The three cases of leptospirosis were severe with complications in the kidneys, lungs, and hematological system requiring intensive care in the ICU. Early and appropriate management can reduce patient mortality rates. In these 3 cases, older age, mechanical ventilation, acute kidney failure, septic shock, thrombocytopenia, and elevated transaminase enzymes were associated with severe leptospirosis and poor outcomes.

Note: This article has supplementary file(s).

Fulltext |  common.other
Letter Application
Subject
Type Other
  Download (270KB)    Indexing metadata
 common.other
Copyright Transfer Agreement
Subject
Type Other
  Download (391KB)    Indexing metadata
Keywords: clinical manifestations; diagnosis; intensive care unit; management; severe leptospirosis

Article Metrics:

Article Info
Section: Case Reports
Language : EN
Recent articles
COMPARISON OF THE EFFECTIVENESS BETWEEN FENTANYL AND KETAMINE AS ADJUVANT EPIDURAL ANALGESIA WITH ROPIVACAINE IN POST OPERATION OF THE LOWER EXTREMITY Enteral Nutrition Tolerability Assessment in Septic Shock Patients in The ICU of RSUP H. Adam Malik Medan Comparison of Laryngeal Mask Airway and Endotracheal Tube on Intraocular Pressure in Vitrectomy Low Dosage Regional Anesthesia for Bladder Tumors in Aortic Stenosis Patient Anesthetic Management of Supraglottic Tumors Undergoing Direct Laryngoscopy A 23-Year-Old Woman with Cerebellopontine Tumor Angle Sectio Caesaria Trans-peritoneal Profunda Surgery Over Oligohydramnios Indication Prevention and Management of Stress Ulcers in Critically ill Patients Use of bronchial toilets in sepsis patients treated in the Intensive Care Unit (ICU): A review study on indications and complications Literature Review: Palliative Care in Intensive Care Units More recent articles
Most cited articles
Patofisiologi Penyakit Jantung Koroner Midazolam Intravena Dosis Rendah Tidak Mempengaruhi Nitric Oxide Intraperitoneal Mencit Balb/C Yang Terpapar Lipopolisakarida More cited articles
  1. Samrot AV, Sean TC, Bhavya KS, Sahithya CS, Chandrasekaran SP, Palanisamy P, Robinson ER, Subbiah SK, Mok PL. Leptospiral Infection, Pathogenesis and Its Diagnosis. Pathogens. 2021;10(2):145
  2. Alian S, Asghari H, Najafi N, Davoudi A, Yazdani J. Corticosteroid in the Treatment of Moderate to Severe Thrombocytopenia Due to Leptospirosis. Iran Red Crescent Med J. 2014;16(10):e16030
  3. Haake DA. Leptospirosis in Humans. Curr Top Microbiol Immunol. 2015;387:65-97
  4. Rajapakse S. Leptospirosis: Clinical Aspects. Clin Med. 2022;22(1):14-7
  5. Karnik ND, Patankar AS. Leptospirosis in Intensive Care Unit. Indian J Crit Care Med. 2021. doi: 10.5005/jp-journals-10071-23852
  6. Smith S, Kennedy BJ, Dermedgoglou A, Poulgrain SS, Paavola MP, Minto TL, Luc M, Liu YS, Hanson J. Simple Score to Predict Severe Leptospirosis. PLoS Negl Trop Dis. 2019;13(2):e0007163
  7. Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14(2):296-326
  8. Fatoni AZ, Kestriani ND. Acute Kidney Injury pada Pasien Kritis. Anesth Crit Care. 2018;(36):64-76
  9. Simbolon OM. Dexamethasone vs Methylprednisolone [Video]. YouTube. https://youtu.be/eg7wzdehQzc
  10. Joseph A, Samant H. Jaundice. National Library of Medicine. 2023
  11. Phipilp N, Lung Than LT, Shah A, Yuhana MY, Sekawi Z, Neela VK. Predictor of Severe Leptospirosis: Multicentre Observational Study From Central Malaysia. BMC Infect Dis. 2021;21(1):1081
  12. Chang ML, Yang CW, Chen JC, Ho YP, Pan MJ, Lin CH. Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis. World J Gastroenterol. 2005;11(35):5553-5556
  13. Wang HK, Lee MH, Chen YC, Hsueh PR, Chang SC. Factors Associated with Severity and Mortality in Patients with Confirmed Leptospirosis at a Regional Hospital in Northern
  14. Taiwan. J Microbiol Immunol Infect. 2018;53:307-314

Last update:

No citation recorded.

Last update: 2024-11-05 02:56:09

No citation recorded.